The prevalence and meaning of eosinophilia in renal diseases on a nephrology consultation service

Nephrology Dialysis Transplantation

Volumn 26, Issue 8, 2011, Pages 2549-2558

  Diskin, Charles J ^a   Stokes, Thomas J ^a   Dansby, Linda M ^a   Radcliff, Lautrec ^a   Carter, Thomas B ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

diagnosis; eosinophil; renal failure; vascular disease; vascular physiology

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CREATININE; PHOSPHORUS; PREDNISONE;

ADULT; AGE; ALLERGY; ARTICLE; AUTOIMMUNE DISEASE; CONSULTATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; INFECTION; KIDNEY DISEASE; LEUKOCYTE COUNT; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PHOSPHATE BLOOD LEVEL; PLEURA EFFUSION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; PROTEINURIA; UREMIA;

ALABAMA; CROSS-SECTIONAL STUDIES; EOSINOPHILIA; EOSINOPHILS; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; KIDNEY DISEASES; MALE; MIDDLE AGED; NEPHROLOGY; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION;

EID: 79961038680     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq745     Document Type: Article

References (88)

1. Wharton Jones T. The blood corpuscle considered in its different phases of development in the animal series. Philos Trans R Soc Lond Biol 1846;1:82-90
2. Samter M, Wasserman SI. Chapter 12, eosinophils. In: Samter M, ed. Immunological Diseases. 3rd edn. Little, Brown & Co; 1978:230-243
3. Akuthota P, Wang HB, Spencer LA et al. Immunoregulatory roles of eosinophils: a new look at a familiar cell. Clin Exp Allergy 2008;38:1254-1263 (Pubitemid 352019674)
4. D'Ambrosio D, Mariani M, Panina-Bordignon P et al. Chemokines and their receptors guiding T lymphocyte recruitment in lung inflammation. Am J Respir Crit Care Med 2001;164:1266-1275 (Pubitemid 33052262)
5. Frigui M, Hmida MB, Jallouli M et al. Membranous glomerulopathy associated with idiopathic hypereosinophilic syndrome. Saudi J Kidney Dis Transpl 2010;21:320-322
6. Motellón JL, Bernis C, García-Sánchez A et al. Renal involvement in the hypereosinophilic syndrome. Nephrol Dial Transplant 1995;10:401-403
7. Voudiklaris S, Virvidakis K, Kalmantis T et al. Eosinophilia in patients undergoing regular hemodialysis. Int J Artif Organs 1983;6:195-198 (Pubitemid 14233414)
8. Hoy WE, Cestero R V M. Eosinophilia in maintenance hemodialysis patients. J Dial 1979;3:73-87 (Pubitemid 10223432)
9. Montoliu J, Lopez-Pedret J, Andreu L et al. Eosinophilia in patients undergoing dialysis. Br Med J 1981;282:2098 (Pubitemid 11122676)
10. Lee CC, Leu ML, Kuo HP et al. Hypereosinophilia in hemodialysis patients. Changgeng Yi Xue Za Zhi 1995;18:20-26
11. Gwinner W, Menne J, Lonnemann G et al. Life-threatening complications of extracorporeal treatment in patients with severe eosinophilia. Int J Artif Organs 2005;28:1224-1227 (Pubitemid 43168808)
12. Thakur SS, Unikowsky B, Prichard S. Eosinophilic peritonitis in CAPD: treatment with prednisone and diphenhydramine. Perit Dial Int 1997;17:402-403 (Pubitemid 27470221)
13. Oh SY, Kim H, Kang JM et al. Eosinophilic peritonitis in a patient with continuous ambulatory peritoneal dialysis (CAPD). Korean J Intern Med 2004;19:121-123 (Pubitemid 41237476)
14. Backenroth R, Spinowitz BS, Galler M et al. Comparison of eosinophilia in patients undergoing peritoneal dialysis and hemodialysis. Am J Kidney Dis 1986;8:186-191 (Pubitemid 17217093)
15. Meleg-Smith S, Gauthier PM. Abundance of interstitial eosinophils in renal allografts is associated with vascular rejection. Transplantation 2005;79:444-450 (Pubitemid 40280177)
16. Thomson PD, Meyers KE. Eosinophilia as an early predictor of acute cellular rejection in pediatric renal transplants. Transplant Proc 1994;26:69-71 (Pubitemid 24080421)
17. Weir MR, Hall-Craggs M, Shen SY et al. The prognostic value of the eosinophil in acute renal allograft rejection. Transplantation 1986;41:709-712 (Pubitemid 16062683)
18. Akinsola A, Durosinmi MO, Akinola NO. The haematological profile of Nigerians with chronic renal failure. Afr J Med Med Sci 2000;29:13-16
19. Dratwa M, Tielemans C, Brenez D. IgE levels in patients with chronic renal failure. N Engl J Med 1981;305:960-961
20. Gabizon D, Kaufman S, Shaked U et al. Eosinophilia in uremia. Nephron 1981;29:36-39 (Pubitemid 12241810)
21. Lye WC, Cheah JS, Sinniah R. Renal cholesterol embolic disease. Case report and review of the literature. Am J Nephrol 1993;13:489-493 (Pubitemid 24041072)
22. Date A, Jacob M, Johny KV. Eosinophilic leukocytes in diffuse proliferative and exudative glomerulonephritis. Am J Trop Med Hyg 1977;26(5 Pt 1):1028-1031 (Pubitemid 8191547)
23. Dejani H, Eisen TD, Finkelstein FO. Revascularization of renal artery stenosis in patients with renal insufficiency. Am J Kidney Dis 2000;36:752-758
24. Ten RM, Torres VE, Milliner DS et al. Acute interstitial nephritis: immunologic and clinical aspects. Mayo Clin Proc 1988;63:921-930
25. Guillevin L, Cohen P, Gayraud M et al. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999;78:26-37 (Pubitemid 29065978)
26. Hegarty J, Chiu DY, Middleton RJ et al. Systemic lupus erythematosus, eosinophilic vasculitis and acalculous cholecystitis. Nephrol Dial Transplant 2006;21:792-795 (Pubitemid 43372931)
27. Kamali S, Kasapoglu E, Aktürk F et al. Eosinophilia and hyperimmunoglobulinemia E as the presenting manifestations of Wegener's granulomatosis. Clin Rheumatol 2003;22:333-335 (Pubitemid 37483631)
28. Ohashi N, Sugiura T, Isozaki T et al. Anti-glomerular basement membrane antibody-induced glomerulonephritis with periglomerular granulomatous reaction and massive renal eosinophilic infiltration. Am J Kidney Dis 2003;42:E28-E35
29. Armstrong WB, Allison G, Pena F et al. Kimura's disease: two case reports and a literature review. Ann Otol Rhinol Laryngol 1998;107:1066-1071 (Pubitemid 28564191)
30. Segev A, Ben-Chitrit S, Orion Y et al. Acute eosinophilic interstitial nephritis and uveitis (TINU syndrome) associated with granulomatous hepatitis. Clin Nephrol 1999;51:310-313 (Pubitemid 29219299)
31. Ducloux D, Chalopin JM. Renal involvement in diffuse fasciitis with eosinophilia. Clin Nephrol 1997;48:204 (Pubitemid 27429614)
32. Kirkland GS, Savige J, Wilson D et al. Classical polyarteritis nodosa and microscopic polyarteritis with medium vessel involvement-a comparison of the clinical and laboratory features. Clin Nephrol 1997;47:176-180 (Pubitemid 27119710)
33. Hermida Lazcano I, Gárcia Díez F, Nerín Sánchez C et al. Eosinophilia: initial presentation form of hypernephroma. An Med Interna 1997;14:320-321
34. Moroni M, Porta C, De Amici M et al. Eosinophils and C4 predict clinical failure of combination immunotherapy with very low dose subcutaneous interleukin-2 and interferon in renal cell carcinoma patients. Haematologica 2000;85:298-303 (Pubitemid 30340148)
35. Hazouard E, Clément B, Ferrandière M et al. Major circulatory and medullary eosinophilia revealing renal cell carcinoma. Presse Med 1998;27:1218 (Pubitemid 28350934)
36. Kawai K, Saijo K, Oikawa T et al. Clinical course and immune response of a renal cell carcinoma patient to adoptive transfer of autologous cytotoxic T lymphocytes. Clin Exp Immunol 2003;134:264-269 (Pubitemid 37372278)
37. Liapis H, Ho AK, Brown D et al. Thrombotic microangiopathy associated with the hypereosinophilic syndrome. Kidney Int 2005;67:1806-1811 (Pubitemid 40577715)
38. Al Aly Z, Philoctête Ashley JM, Gellens ME et al. Thrombotic thrombocytopenic purpura in a patient treated with imatinib mesylate: true association or mere coincidence? Am J Kidney Dis 2005;45:762-768 (Pubitemid 40460765)
39. Levey AS, Bosch JP, Lewis JB et al. A more accurate way to measure glomerular filtration rate from serum creatinine. Modification of Diet in renal Disease Study Group. Ann Intern Med 1999;130:461-470
40. Uchiyama-Tanaka Y, Mori Y, Matsubara H. Increased eosinophilia after transfer of a patient to peritoneal dialysis for resolution of a hemodialysis-associated hypersensitivity reaction. Clin Nephrol 2007;67:129-130 (Pubitemid 46322567)
41. Szczeklik A, Podolec Z. Central regulation of blood eosinophilia by the beta-adrenergic system in rats. Int Arch Allergy Appl Immunol 1976;50:328-340
42. Abidi K, Khoudri I, Belayachi J et al. Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units. Crit Care 2008;12:R59
43. López de Toro Martín Consuegra I, Sánchez Casado M, Rodríguez Villar S et al. Evaluation of eosinopenia as an infection marker in critical care patients. Med Intensiva 2010;34:246-253
44. Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 1999;34:1114-1124
45. Diskin CJ, Stokes TJ. Efficacy of an attachable silver impregnated subcutaneous cuff for the prevention of catheter-associated infections in patients on chronic maintenance hemodialysis. Nephron 1995;69:357-359
46. Diskin CJ. Heparin, biofilm, and catheter-related sepsis. Diagn Microbiol Infect Dis 2008;61:80 (Pubitemid 351515887)
47. Diskin CJ, Stokes TJ, Dansby LM et al. Case report and review: is the tendency for Curvularia tubular obstruction significant in pathogenesis? Perit Dial Int 2008;28:678-679
48. Diskin CJ, Stokes TJ, Dansby LM et al. Is systemic heparin a risk factor for catheter-related sepsis in dialysis patients? An evaluation of various biofilm and traditional risk factors. Nephron Clin Pract 2007;107:c128-c132
49. Coplon NS, Diskin CJ, Petersen J et al. The long-term clinical course of systemic lupus erythematosus in end-stage renal disease. N Engl J Med 1983;308:186-190 (Pubitemid 13171137)
50. Diskin CJ. Looking backward: a review of the treatment of systemic lupus erythematosus in end-stage renal disease after a quarter of century. Nephrol Dial Transplant 2006;21:1739 (Pubitemid 43834658)
51. Diskin CJ. The role of the nephrologist in the treatment of lupus nephritis. Nat Clin Pract Nephrol 2007;3:E1
52. Wintrobe MM (ed). Eosinophilia. In Chapter IV, The Leukocytes in: Clinical Hematology. 1st edn. Philadelphia, PA: Lea & Febiger, 1947:172-175.
53. Kobayashi T, Takaku Y, Yokote A et al. Interferon-beta augments eosinophil adhesion-inducing activity of endothelial cells. Eur Respir J 2008;32:1540-1547
54. Diskin CJ, Stokes TJ, Dansby LM et al. Towards an understanding of oedema. BMJ 1999;318:1610-1613 (Pubitemid 29267778)
55. Diskin CJ, Stokes TJ, Dansby LM et al. Understanding the pathophysiology of hemodialysis access problems as a prelude to developing innovative therapies. Nat Clin Pract Nephrol 2008;4:628-638
56. Suliman ME, Yilmaz MI, Carrero JJ et al. Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease. Clin J Am Soc Nephrol 2008;3:976-985
57. Segal N, Levy Y, Garty B et al. Prevalence and Causes of Moderate-Severe Eosinophilia in Children. J Allergy Clin Immunol 2006;117:S64
58. Christensen RD, Jensen J, Maheshwari A et al. Reference ranges for blood concentrations of eosinophils and monocytes during the neonatal period defined from over 63 000 records in a multihospital health-care system. J Perinatol 2010;30:540-545
59. Chiardola F, Schneeberger EE, Citera G et al. Prevalence and clinical significance of eosinophilia in patients with rheumatoid arthritis in Argentina. J Clin Rheumatol 2008;14:211-213
60. Bodner G, Peer G, Zakuth V et al. Dialysis-induced eosinophilia. Nephron 1982;32:63-66 (Pubitemid 12006087)
61. Dash PK, Joshi HC. Clinico-biochemical studies on acute toxic nephropathy in goats due to uranyl nitrate. Vet Hum Toxicol 1989;31:5-9 (Pubitemid 19039372)
62. Maia LP, Martins-Filho OA, Teixeira-Carvalho A et al. Hepatitis C virus screening and clinical monitoring of biomarkers in patients undergoing hemodialysis. J Med Virol 2009;81:1220-1231
63. Bahlmann FH, Speer T, Fliser D. Endothelial progenitor cells in chronic kidney disease. Nephrol Dial Transplant 2010;25:341-346
64. Emanuele E, Falcone C, D'Angelo A et al. Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease. Atherosclerosis 2006;186:140-145
65. Haley KJ, Lilly CM, Yang JH et al. Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation 2000;102:2185-2189
66. Ueki S, Kihara J, Kato H et al. Soluble vascular cell adhesion molecule-1 induces human eosinophil migration. Allergy 2009;64:718-724
67. Bäck M, Sakata K, Qiu H et al. Endothelium-dependent vascular responses induced by leukotriene B4. Prostaglandins Other Lipid Mediat 2007;83:209-212 (Pubitemid 46661260)
68. Lee HM, Kim HJ, Won KJ et al. Soluble form of vascular cell adhesion molecule 1 induces migration and proliferation of vascular smooth muscle cells. J Vasc Res 2008;45:259-268 (Pubitemid 351543150)
69. Schleimer RP, Sterbinsky SA, Kaiser J et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 1992;148:1086-1092
70. Chihara J, Kakazu T, Higashimoto I et al. Signaling through the beta2 integrin prolongs eosinophil survival. J Allergy Clin Immunol 2000;106(1 Pt 2):S99-103 (Pubitemid 30482842)
71. Yamaguchi K, Ueki S. Role of adhesion molecules in eosinophil activation: the effect of adhesion molecules on eosinophil survival. Allergol Int 2004;53:185-190 (Pubitemid 38899631)
72. Wang JG, Mahmud SA, Thompson JA et al. The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states. Blood 2006;107:558-565 (Pubitemid 43076379)
73. Dallaire MJ, Ferland C, Pagé N et al. Endothelial cells modulate eosinophil surface markers and mediator release. Eur Respir J 2003;21:918-924 (Pubitemid 36675604)
74. Kojima K, Sasaki T. Veno-occlusive disease in hypereosinophilic syndrome. Intern Med 1995;34:1194-1197
75. Reinhardt C. New locations of intravascular tissue factor: indications. Hamostaseologie 2007;27:55-58 (Pubitemid 46280050)
76. Ge CL, Hao CL, Tang NB et al. Changes of exhaled nitric oxide and peripheral blood eosinophils in children with asthma. Zhongguo Dang Dai Er Ke Za Zhi 2009;11:986-988
77. Garcia-Marcos L, Brand PL. The utility of sputum eosinophils and exhaled nitric oxide for monitoring asthma control with special attention to childhood asthma. Allergol Immunopathol (Madr) 2010;38:41-46
78. Radomski MW, Palmer R M J, Moncada S. The role of nitric oxide and c GMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Comm 1987;148:1482-1489 (Pubitemid 18074679)
79. Luscher TF, Diederich D, Siebenmann R et al. Difference between endothelium dependent relaxation in arterial and venous coronary artery bypass graft. N Engl J Med 1988;319:462-467
80. Komri K, Gloviczki P, Bourchier RG et al. Endothelium dependent vasorelaxations in response to aggregating platelets are impaired in reverse vein grafts. J Vasc surg 1990;12:139-147 (Pubitemid 20246986)
81. Walker AE, Seibert SM, Donato AJ et al. Vascular endothelial function is related to white blood cell count and myeloperoxidase among healthy middle-aged and older adults. Hypertension 2010;55:363-369
82. Hospers JJ, Schouten JP, Weiss ST et al. Eosinophilia is associated with increased all-cause mortality after a follow-up of 30 years in a general population sample. Epidemiology 2000;11:261-268 (Pubitemid 30228192)
83. Hospers JJ, Rijcken B, Schouten JP et al. Eosinophilia and positive skin tests predict cardiovascular mortality in a general population sample followed for 30 years. Am J Epidemiol 1999;150:482-491 (Pubitemid 29407232)
84. Sweetnam PM, Thomas HF, Yarnell JW et al. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. Am J Epidemiol 1997;145:416-421 (Pubitemid 27084213)
85. Gabbasov ZA, Kozlov SG, Lyakishev AA et al. Polymorphonuclear blood leukocytes and restenosis after intracoronary implantation of drug-eluting stents. Can J Physiol Pharmacol 2009;87:130-136
86. Rittersma SZ, Meuwissen M, van der Loos CM et al. Eosinophilic infiltration in restenotic tissue following coronary stent implantation. Atherosclerosis 2006;184:157-162 (Pubitemid 41721083)
87. Ziakka S, Ursu M, Poulikakos D et al. Predictive factors and therapeutic approach of renovascular disease: four years' follow-up. Ren Fail 2008;30:965-970
88. Siddiqui S, MacGregor MS, Glynn C et al. Factors predicting outcome in a cohort of patients with atherosclerotic renal artery disease diagnosed by magnetic resonance angiography. Am J Kidney Dis 2005;46:1065-1073 (Pubitemid 41690232)